Teleflex (TFX) Competitors

Insulet (NASDAQ:PODD) and Teleflex (NYSE:TFX) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, community ranking, earnings, analyst recommendations, risk, valuation, dividends, media sentiment and institutional ownership.

Do analysts recommend PODD or TFX?

Insulet currently has a consensus target price of $306.53, indicating a potential downside of 6.39%. Teleflex has a consensus target price of $164.63, indicating a potential upside of 29.95%. Given Teleflex's higher probable upside, analysts clearly believe Teleflex is more favorable than Insulet.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Insulet	0 Sell rating(s)	3 Hold rating(s)	14 Buy rating(s)	0 Strong Buy rating(s)	2.82
Teleflex	1 Sell rating(s)	8 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.09

Does the MarketBeat Community prefer PODD or TFX?

Insulet received 211 more outperform votes than Teleflex when rated by MarketBeat users. Likewise, 66.31% of users gave Insulet an outperform vote while only 58.36% of users gave Teleflex an outperform vote.

Company	Underperform	Outperform
Insulet	Outperform Votes 738 66.31%	Underperform Votes 375 33.69%
Teleflex	Outperform Votes 527 58.36%	Underperform Votes 376 41.64%

Which has more risk & volatility, PODD or TFX?

Insulet has a beta of 1.26, meaning that its share price is 26% more volatile than the S&P 500. Comparatively, Teleflex has a beta of 1.17, meaning that its share price is 17% more volatile than the S&P 500.

Does the media refer more to PODD or TFX?

In the previous week, Insulet and Insulet both had 26 articles in the media. Insulet's average media sentiment score of 1.11 beat Teleflex's score of 0.65 indicating that Insulet is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Insulet	18 Very Positive mention(s)	2 Positive mention(s)	4 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Teleflex	11 Very Positive mention(s)	1 Positive mention(s)	9 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive

Is PODD or TFX more profitable?

Insulet has a net margin of 20.19% compared to Teleflex's net margin of 7.85%. Insulet's return on equity of 24.46% beat Teleflex's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Insulet	20.19%	24.46%	8.33%
Teleflex	7.85%	14.19%	8.53%

Which has better earnings and valuation, PODD or TFX?

Teleflex has higher revenue and earnings than Insulet. Teleflex is trading at a lower price-to-earnings ratio than Insulet, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Insulet	$2.20B	10.48	$206.30M	$5.56	58.90
Teleflex	$3.01B	1.86	$356.33M	$3.17	39.96

Do institutionals and insiders believe in PODD or TFX?

95.6% of Teleflex shares are held by institutional investors. 0.4% of Insulet shares are held by insiders. Comparatively, 1.4% of Teleflex shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Summary

Insulet beats Teleflex on 11 of the 17 factors compared between the two stocks.